# TRANYLCYPROMINE SULFATE
> **ANDA213503** · Abbreviated New Drug Application (Generic) · Sponsor: CROSSMEDIKA SA · Approved 2022-06-27
## Drug
- **FDA Application Number:** ANDA213503
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TRANYLCYPROMINE SULFATE
- **Generic name:** TRANYLCYPROMINE
- **Active ingredients:** TRANYLCYPROMINE SULFATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CROSSMEDIKA SA
- **Manufacturer:** Solco Healthcare US, LLC
- **First approval:** 2022-06-27
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213503)
---
*AI Analytics · CC0 1.0*